Log In
Print
BCIQ
Print
Print this Print this
 

MTL-501

  Manage Alerts
Collapse Summary General Information
Company MiNA Therapeutics Ltd.
DescriptionShort activating RNA (saRNA) that activates the CEBPA gene
Molecular Target CCAAT enhancer binding protein alpha (CEBPA)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular cancer (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today